In this episode, Dr. Joseph Sinkule, CEO of Klotho Neurosciences, discusses his extensive background in medical research and entrepreneurship, focusing on the development of innovative therapies for age-related cognitive and neurodegenerative disorders. He explains the significance of the Klotho protein, its potential in gene therapy, and the company's strategic approach to addressing diseases like Alzheimer's and ALS. The discussion also touches on the importance of diagnostics and the future vision for extending healthy lifespans.Klotho Neurosciences website: https://klothoneuro.com/Episode NotesDr. Sinkule has transitioned from clinical practice to entrepreneurship over 46 years.Klotho Neurosciences focuses on developing therapies for neurodegenerative diseases.The Klotho protein is linked to anti-aging and cognitive enhancement.Gene therapy using Klotho has potential applications in ALS and Alzheimer's.Diagnostics play a crucial role in identifying candidates for Clotho therapies.The company aims to balance research with practical business strategies.Dr. Sinkule emphasizes the importance of early intervention in neurodegenerative diseases.Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

Ver todos los episodios